Clinical Trial of L. Reuteri in Infantile Colic 2017

NAUnknownINTERVENTIONAL
Enrollment

244

Participants

Timeline

Start Date

January 1, 2018

Primary Completion Date

November 30, 2019

Study Completion Date

January 30, 2020

Conditions
Infantile Colic
Interventions
DIETARY_SUPPLEMENT

L. reuteri DSM 17938 in drops

L. reuteri DSM 17938 will be given at a dose of 5 drops containing 1x108 colony-forming units (CFU) once time per day in an oil formulation delivered from a drop bottle

OTHER

Placebo

The placebo consists of an identical formulation except that the L. reuteri is not present

Trial Locations (1)

14080

RECRUITING

Hospital General Dr. Manuel Gea Gonzalez, Mexico City

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

BioGaia AB

INDUSTRY

lead

Innovacion y Desarrollo de Estrategias en Salud

OTHER

NCT03360253 - Clinical Trial of L. Reuteri in Infantile Colic 2017 | Biotech Hunter | Biotech Hunter